Given the challenges of enteral nutrition in CHD patients postoperatively (20, 21) particularly due to the risk of gastrointestinal complications, we evaluated the diagnostic and prognostic utility of IFABP and TFF3 in this setting. The gene discussed is TFF3; the disease is coronary artery disorder.